RT Journal Article
SR Electronic
T1 A Data Driven Change-point Epidemic Model for Assessing the Impact of Large Gathering and Subsequent Movement Control Order on COVID-19 Spread in Malaysia
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.20.20233890
DO 10.1101/2020.11.20.20233890
A1 Dass, Sarat C.
A1 Kwok, Wai M.
A1 Gibson, Gavin J.
A1 Gill, Balvinder S.
A1 Sundram, Bala M.
A1 Singh, Sarbhan
YR 2020
UL http://medrxiv.org/content/early/2020/11/23/2020.11.20.20233890.abstract
AB The second wave of COVID-19 in Malaysia is largely attributed to a mass gathering held in Sri Petaling between February 27, 2020 and March 1, 2020, which contributed to an exponential rise of COVID-19 cases in the country. Starting March 18, 2020, the Malaysian government introduced four consecutive phases of a Movement Control Order (MCO) to stem the spread of COVID-19. The MCO was implemented through various non-pharmaceutical interventions (NPIs). The reported number of cases reached its peak by the first week of April and then started to reduce, hence proving the effectiveness of the MCO. To gain a quantitative understanding of the effect of MCO on the dynamics of COVID-19, this paper develops a class of mathematical models to capture the disease spread before and after MCO implementation in Malaysia. A heterogeneous variant of the Susceptible-Exposed-Infected-Recovered (SEIR) model is developed with additional compartments for asymptomatic transmission. Further, a change-point is incorporated to model the before and after disease dynamics, and is inferred based on data. Related statistical analyses for inference are developed in a Bayesian framework and are able to provide quantitative assessments of (1) the impact of the Sri Petaling gathering, and (2) the extent of decreasing transmission during the MCO period. The analysis here also quantitatively demonstrates how quickly transmission rates fall under effective NPI implemention within a short time period.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding for this work is provided by the Global Challenges Research Fund (GCRF) “Post MCO Strategies for Controlling Covid-19 in Malaysia” (Award no. 831077/ SFC-GCRF 2019-2020 COVID-19 Round) by the Scottish Funding Council (http://www.sfc.ac.uk/) and Heriot-Watt University (https://www.hw.ac.uk/).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data is open source and can be accessed from these links: https://www.outbreak.my/ and http://covid-19.moh.gov.my/. https://www.outbreak.my/ http://covid-19.moh.gov.my/